The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predicting significance of EGFR mutation existing in tissues and plasma concuurrently or alone to EGFR–tyrosine kinase inhibitors (EGFR-TKIs) for advanced non-small cell lung cancer.
Yuyan Wang
No relevant relationships to disclose
Jie Wang
Research Funding - National Science Foundation for Distinguished Young Scholars of China 
Hua Bai
Research Funding - National Natural Science Foundation of China
Zhijie Wang
Research Funding - National Natural Science Foundation of China
Jianchun Duan
No relevant relationships to disclose
Tongtong An
No relevant relationships to disclose
Jun Zhao
No relevant relationships to disclose
Minglei Zhuo
No relevant relationships to disclose
Meina Wu
No relevant relationships to disclose
Shuhang Wang
Research Funding - National Natural Science Foundation of China